The stratification of patients with metastatic Renal Cell Carcinoma (mRCC) into risk categories is mandatory to create a prognostic scoring systems and to guide an adequate therapeutic decisions. The aim of this article is to describe the main biological and clinical factors impacting on treatment decision-making
To cite this article
Metastatic renal cancer: prognostic and predictive biomarkers review
WCRJ 2014; 1 (3): e289
Published online: 01 Oct 2014
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.